Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-07-26

FDA Approved: LISDEXAMFETAMINE DIMESYLATE — Original Application (Sandoz Inc)

View source ↗

Summary

The FDA approved Sandoz Inc's original generic application for lisdexamfetamine dimesylate, authorizing its use as a stimulant medication. The product is intend…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

ORIG AP for LISDEXAMFETAMINE DIMESYLATE (LISDEXAMFETAMINE DIMESYLATE)